{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:15:38Z","timestamp":1787724938379,"version":"build-2784847793"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:00Z","timestamp":1780099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"vor","delay-in-days":65,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences and Health Services","doi-asserted-by":"publisher","award":["IR. TUMS.NI.REC.1401.059"],"award-info":[{"award-number":["IR. TUMS.NI.REC.1401.059"]}],"id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-026-04971-w","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T11:24:57Z","timestamp":1780140297000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association between body composition and disease progression in adults with amyotrophic lateral sclerosis: a cross-sectional study"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-5669-1591","authenticated-orcid":false,"given":"Hamid","family":"Abbasi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrnoosh","family":"Shafaatdoost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6809-1100","authenticated-orcid":false,"given":"Arefeh","family":"Mohajerani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1111-1948","authenticated-orcid":false,"given":"Milad","family":"Asadollahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Rashidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Malekahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8386-5493","authenticated-orcid":false,"given":"Payam","family":"Sarraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,30]]},"reference":[{"issue":"10107","key":"4971_CR1","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1016\/S0140-6736(17)31287-4","volume":"390","author":"MA van Es","year":"2017","unstructured":"van Es MA, et al. Amyotrophic lateral sclerosis. Lancet. 2017;390(10107):2084\u201398.","journal-title":"Lancet"},{"issue":"1","key":"4971_CR2","first-page":"1","volume":"3","author":"O Hardiman","year":"2017","unstructured":"Hardiman O, et al. Amyotrophic lateral sclerosis. Nat Rev Dis Primers. 2017;3(1):1\u201319.","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"4971_CR3","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1097\/WCO.0000000000000730","volume":"32","author":"E Longinetti","year":"2019","unstructured":"Longinetti E, Fang F. Epidemiology of amyotrophic lateral sclerosis: an update of recent literature. Curr Opin Neurol. 2019;32(5):771\u20136.","journal-title":"Curr Opin Neurol"},{"issue":"1","key":"4971_CR4","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/S1474-4422(17)30401-5","volume":"17","author":"R Chia","year":"2018","unstructured":"Chia R, Chi\u00f2 A, Traynor BJ. Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications. Lancet Neurol. 2018;17(1):94\u2013102.","journal-title":"Lancet Neurol"},{"issue":"3","key":"4971_CR5","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1136\/jmedgenet-2016-104271","volume":"54","author":"A-L Ji","year":"2017","unstructured":"Ji A-L, et al. Genetics insight into the amyotrophic lateral sclerosis\/frontotemporal dementia spectrum. J Med Genet. 2017;54(3):145\u201354.","journal-title":"J Med Genet"},{"issue":"10","key":"4971_CR6","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1136\/jnnp-2015-310471","volume":"86","author":"L Chen","year":"2015","unstructured":"Chen L, et al. Natural history and clinical features of sporadic amyotrophic lateral sclerosis in China. J Neurol Neurosurg Psychiatry. 2015;86(10):1075\u201381.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"4971_CR7","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1136\/jnnp-2018-319611","volume":"90","author":"C Moglia","year":"2019","unstructured":"Moglia C, et al. Early weight loss in amyotrophic lateral sclerosis: outcome relevance and clinical correlates in a population-based cohort. J Neurol Neurosurg Psychiatry. 2019;90(6):666\u201373.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7-8","key":"4971_CR8","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1080\/21678421.2019.1621346","volume":"20","author":"ST Ngo","year":"2019","unstructured":"Ngo ST, et al. Loss of appetite is associated with a loss of weight and fat mass in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20(7\u20138):497\u2013505.","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"2","key":"4971_CR9","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s10072-018-3672-z","volume":"40","author":"C Tarlarini","year":"2019","unstructured":"Tarlarini C, et al. Taste changes in amyotrophic lateral sclerosis and effects on quality of life. Neurol Sci. 2019;40(2):399\u2013404.","journal-title":"Neurol Sci"},{"key":"4971_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2020.117257","volume":"420","author":"P Fayemendy","year":"2021","unstructured":"Fayemendy P, et al. Hypermetabolism is a reality in amyotrophic lateral sclerosis compared to healthy subjects. J Neurol Sci. 2021;420:117257.","journal-title":"J Neurol Sci"},{"issue":"1","key":"4971_CR11","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/ene.13468","volume":"25","author":"P J\u00e9sus","year":"2018","unstructured":"J\u00e9sus P, et al. Hypermetabolism is a deleterious prognostic factor in patients with amyotrophic lateral sclerosis. Eur J Neurol. 2018;25(1):97\u2013104.","journal-title":"Eur J Neurol"},{"issue":"10","key":"4971_CR12","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1136\/jnnp-2017-317887","volume":"89","author":"FJ Steyn","year":"2018","unstructured":"Steyn FJ, et al. Hypermetabolism in ALS is associated with greater functional decline and shorter survival. J Neurol Neurosurg Psychiatry. 2018;89(10):1016\u201323.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4971_CR13","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1007\/s10072-019-04201-x","volume":"41","author":"B Che\u0142stowska","year":"2020","unstructured":"Che\u0142stowska B, Ku\u017ama-Kozakiewicz M. Biochemical parameters in determination of nutritional status in amyotrophic lateral sclerosis. Neurol Sci. 2020;41:1115\u201324.","journal-title":"Neurol Sci"},{"key":"4971_CR14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/0022-510X(95)00061-6","volume":"129","author":"KL Nau","year":"1995","unstructured":"Nau KL, et al. Individuals with amyotrophic lateral sclerosis are in caloric balance despite losses in mass. J Neurol Sci. 1995;129:47\u20139.","journal-title":"J Neurol Sci"},{"issue":"6","key":"4971_CR15","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1136\/jnnp.2010.211474","volume":"82","author":"B Marin","year":"2011","unstructured":"Marin B, et al. Alteration of nutritional status at diagnosis is a prognostic factor for survival of amyotrophic lateral sclerosis patients. J Neurol Neurosurg Psychiatry. 2011;82(6):628\u201334.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"4971_CR16","doi-asserted-by":"publisher","first-page":"13292","DOI":"10.1038\/s41598-022-16229-9","volume":"12","author":"J-Y Li","year":"2022","unstructured":"Li J-Y, et al. Correlation of weight and body composition with disease progression rate in patients with amyotrophic lateral sclerosis. Sci Rep. 2022;12(1):13292.","journal-title":"Sci Rep"},{"issue":"4","key":"4971_CR17","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1002\/mus.24419","volume":"51","author":"V Roubeau","year":"2015","unstructured":"Roubeau V, et al. Nutritional assessment of amyotrophic lateral sclerosis in routine practice: value of weighing and bioelectrical impedance analysis. Muscle Nerve. 2015;51(4):479\u201384.","journal-title":"Muscle Nerve"},{"issue":"6","key":"4971_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0067783","volume":"8","author":"E Lindauer","year":"2013","unstructured":"Lindauer E, et al. Adipose tissue distribution predicts survival in amyotrophic lateral sclerosis. PLoS ONE. 2013;8(6):e67783.","journal-title":"PLoS ONE"},{"issue":"10","key":"4971_CR19","first-page":"1023","volume":"59","author":"H Nodera","year":"2007","unstructured":"Nodera H, Izumi Y, Kaji R. New diagnostic criteria of ALS (Awaji criteria). Brain Nerve. 2007;59(10):1023\u20139.","journal-title":"Brain Nerve"},{"key":"4971_CR20","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/0022-510X(94)90191-0","volume":"124","author":"BR Brooks","year":"1994","unstructured":"Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases\/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial\" clinical limits of amyotrophic lateral sclerosis\" workshop contributors. J Neurol Sci. 1994;124:96\u2013107.","journal-title":"J Neurol Sci"},{"issue":"8","key":"4971_CR21","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1249\/01.MSS.0000078924.61453.FB","volume":"35","author":"CL Craig","year":"2003","unstructured":"Craig CL, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381\u201395.","journal-title":"Med Sci Sports Exerc"},{"issue":"12","key":"4971_CR22","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1136\/jnnp-2012-304701","volume":"84","author":"F Franchignoni","year":"2013","unstructured":"Franchignoni F, et al. Evidence of multidimensionality in the ALSFRS-R scale: a critical appraisal on its measurement properties using Rasch analysis. J Neurol Neurosurg Psychiatry. 2013;84(12):1340\u20135.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"11","key":"4971_CR23","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1002\/mus.880141111","volume":"14","author":"RP Kleyweg","year":"1991","unstructured":"Kleyweg RP, Van Der Mech\u00e9 FG, Schmitz PI. Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain\u2010Barr\u00e9 syndrome. Muscle Nerve. 1991;14(11):1103\u20139.","journal-title":"Muscle Nerve"},{"key":"4971_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/cc13052","volume":"17","author":"BA Connolly","year":"2013","unstructured":"Connolly BA, et al. Clinical predictive value of manual muscle strength testing during critical illness: an observational cohort study. Crit Care. 2013;17:1\u20139.","journal-title":"Crit Care"},{"issue":"1","key":"4971_CR25","first-page":"12","volume":"87","author":"P Steinacker","year":"2016","unstructured":"Steinacker P, et al. Neurofilaments in the diagnosis of motoneuron diseases: a prospective study on 455 patients. J Neurol Neurosurg Psychiatry. 2016;87(1):12\u201320.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4971_CR26","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/978-981-97-3385-9_10","volume-title":"R Programming: Statistical Data Analysis in Research","author":"K Okoye","year":"2024","unstructured":"Okoye K, Hosseini S. Chi-Squared (X2) statistical test in R. In: R Programming: Statistical Data Analysis in Research. Springer; 2024. p. 211\u201323."},{"issue":"9","key":"4971_CR27","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3390\/computers12090172","volume":"12","author":"J Ochoa-Alde\u00e1n","year":"2023","unstructured":"Ochoa-Alde\u00e1n J, Silva-C\u00e1rdenas C. A new linear model for the calculation of routing metrics in 802.11 s using ns-3 and RStudio. Computers. 2023;12(9):172.","journal-title":"Computers"},{"key":"4971_CR28","doi-asserted-by":"crossref","unstructured":"Kumar L, Tyagi V. Understanding the concepts of tools and techniques for data analysis using RStudio. In Recent trends and future direction for data analytics. IGI Global Scientific Publishing; 2024. pp. 197\u2013213.","DOI":"10.4018\/979-8-3693-3609-0.ch008"},{"issue":"1-2","key":"4971_CR29","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.tox.2013.04.004","volume":"311","author":"C Cervetto","year":"2013","unstructured":"Cervetto C, et al. Motor neuron dysfunction in a mouse model of ALS: gender-dependent effect of P2X7 antagonism. Toxicology. 2013;311(1\u20132):69\u201377.","journal-title":"Toxicology"},{"key":"4971_CR30","doi-asserted-by":"crossref","unstructured":"Dupuis L, Chio A. The \u201cmetabolic axis\u201d of ALS: The role of body weight in disease pathogenesis. Muscle & Nerve. 2023 Mar;67(3):191-2.","DOI":"10.1002\/mus.27784"},{"key":"4971_CR31","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1007\/s00415-019-09276-2","volume":"266","author":"T Shimizu","year":"2019","unstructured":"Shimizu T, et al. Prognostic significance of body weight variation after diagnosis in ALS: a single-centre prospective cohort study. J Neurol. 2019;266:1412\u201320.","journal-title":"J Neurol"},{"key":"4971_CR32","doi-asserted-by":"crossref","unstructured":"Nakayama Y, Shimizu T, Matsuda C, Haraguchi M, Hayashi K, Bokuda K, Nagao M, Kawata A, Ishikawa-Takata K, Isozaki E. Body weight variationpredicts disease progression after invasive ventilation in amyotrophic lateral sclerosis. Scientific Reports. 2019 Aug 22;9(1):12262.","DOI":"10.1038\/s41598-019-48831-9"},{"key":"4971_CR33","doi-asserted-by":"crossref","unstructured":"Iacoangeli A, Lin T, Al Khleifat A, Jones AR, Opie-Martin S, Coleman JR,Shatunov A, Sproviero W, Williams KL, Garton F, Restuadi R. Genome-widemeta-analysis finds the ACSL5-ZDHHC6 locus is associated with ALS and links weight loss to the disease genetics. Cell reports. 2020 Oct 27;33(4).","DOI":"10.1016\/j.celrep.2020.108323"},{"key":"4971_CR34","doi-asserted-by":"crossref","unstructured":"Tandan R, Levy EA, Howard DB, Hiser J, Kokinda N, Dey S, Kasarskis EJ. Body composition in amyotrophic lateral sclerosis subjects and its effect on disease progression and survival. The American journal of clinical nutrition. 2022 May;115(5):1378-92.","DOI":"10.1093\/ajcn\/nqac016"},{"key":"4971_CR35","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1136\/jnnp-2017-317887","volume":"89","author":"F Steyn","year":"2018","unstructured":"Steyn F, et al. Hypermetabolism in ALS is associated with greater functional decline and shorter survival. J Neurol Neurosurg Psychiatry. 2018;89:1016\u201323.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4971_CR36","doi-asserted-by":"crossref","unstructured":"Vucic S. Hypermetabolism appears to be an adverse prognostic biomarker in amyotrophic lateral sclerosis: a potential for therapeutic intervention?. European Journal of Neurology. 2018 Jan;25(1):1-2.","DOI":"10.1111\/ene.13470"},{"key":"4971_CR37","doi-asserted-by":"crossref","unstructured":"Lee I, Kazamel M, McPherson T, McAdam J, Bamman M, Amara A, Smith Jr DL,King PH. Fat mass loss correlates with faster disease progression in amyotrophic lateral sclerosis patients: Exploring the utility of dual-energy x-ray absorptiometry in a prospective study. PLoS One. 2021 May 6;16(5):e0251087.","DOI":"10.1371\/journal.pone.0251087"},{"key":"4971_CR38","unstructured":"Ahmed RM, Highton-Williamson E, Caga J, Thornton N, Ramsey E, Zoing M, Piguet O, Hodges J, Halliday G, Farooqi S, Kiernan MC. 013 Lipid metabolism and body composition in frontotemporal dementia-amyotrophic lateral sclerosis spectrum: effect on survival and disease progression."},{"key":"4971_CR39","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.jns.2014.02.035","volume":"340","author":"S Ngo","year":"2014","unstructured":"Ngo S, et al. Body mass index and dietary intervention: implications for prognosis of amyotrophic lateral sclerosis. J Neurol Sci. 2014;340:5\u201312.","journal-title":"J Neurol Sci"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-026-04971-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-04971-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-04971-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T23:03:35Z","timestamp":1785798215000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12883-026-04971-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,30]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4971"],"URL":"https:\/\/doi.org\/10.1186\/s12883-026-04971-w","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,30]]},"assertion":[{"value":"13 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki, and approved by the Ethics Committee of Tehran University of Medical Sciences and Health Services, Neuroscience Institute, Tehran (with ID number: IR. TUMS.NI.REC.1401.059). The Participants completed a written consent prior of including into the study and being informed about study protocol. All procedures in this study were carried out in compliance with relevant guidelines\/regulations and the Declaration of Helsinki. Participants provided informed consent prior to their involvement in the study and were afforded the option to withdraw at any time. The study ensured that patient anonymity and confidentiality were strictly maintained.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"493"}}